PURPOSE: ALY, an essential mRNA export factor, is dysregulated in a wide variety of human malignancies. However, little is known about the relevance of ALY to oral squamous cell carcinoma (OSCC). The purpose of this study was to investigate ALY expression and its functional mechanisms in OSCCs. METHODS: ALY mRNA and protein expression in seven OSCC-derived cell lines (Sa3, HO-1-u-1, KON, Ca9-22, HSC-2, HSC-3, and HSC-4) and primary OSCCs were analyzed by quantitative reverse transcriptase-polymerase chain reaction, immunoblotting, and immunohistochemistry. We evaluated cellular invasiveness, migration, and the expression levels of metastasis modulators, ribosomal RNA processing 1 homolog B (RRP1B) and CD82, in ALY knockdown cells. RESULTS: ALY was frequently up-regulated in OSCC-derived cell lines and primary OSCCs compared with normal counterparts at both the mRNA and protein expression levels. ALY-positive expression was correlated significantly (P < 0.05) with a higher risk of regional lymph node metastasis. Furthermore, ALY knockdown cells caused a significant (P < 0.05) decrease in cellular invasiveness and migration with up-regulation of RRP1B and CD82 compared with the control cells. CONCLUSION: Our results showed that ALY is linked to regional lymph node metastasis by regulating cellular invasiveness and migration. Therefore, ALY might be a potential biomarker for early detection of lymph node metastasis in OSCCs.
PURPOSE:ALY, an essential mRNA export factor, is dysregulated in a wide variety of humanmalignancies. However, little is known about the relevance of ALY to oral squamous cell carcinoma (OSCC). The purpose of this study was to investigate ALY expression and its functional mechanisms in OSCCs. METHODS:ALY mRNA and protein expression in seven OSCC-derived cell lines (Sa3, HO-1-u-1, KON, Ca9-22, HSC-2, HSC-3, and HSC-4) and primary OSCCs were analyzed by quantitative reverse transcriptase-polymerase chain reaction, immunoblotting, and immunohistochemistry. We evaluated cellular invasiveness, migration, and the expression levels of metastasis modulators, ribosomal RNA processing 1 homolog B (RRP1B) and CD82, in ALY knockdown cells. RESULTS:ALY was frequently up-regulated in OSCC-derived cell lines and primary OSCCs compared with normal counterparts at both the mRNA and protein expression levels. ALY-positive expression was correlated significantly (P < 0.05) with a higher risk of regional lymph node metastasis. Furthermore, ALY knockdown cells caused a significant (P < 0.05) decrease in cellular invasiveness and migration with up-regulation of RRP1B and CD82 compared with the control cells. CONCLUSION: Our results showed that ALY is linked to regional lymph node metastasis by regulating cellular invasiveness and migration. Therefore, ALY might be a potential biomarker for early detection of lymph node metastasis in OSCCs.
Authors: Shanchun Guo; Mohamed-Ali Hakimi; David Baillat; Xiaowei Chen; Michele J Farber; Andres J P Klein-Szanto; Neil S Cooch; Andrew K Godwin; Ramin Shiekhattar Journal: Cancer Res Date: 2005-04-15 Impact factor: 12.701
Authors: M Sho; M Adachi; T Taki; H Hashida; T Konishi; C L Huang; N Ikeda; Y Nakajima; H Kanehiro; M Hisanaga; H Nakano; M Miyake Journal: Int J Cancer Date: 1998-10-23 Impact factor: 7.396
Authors: Pauline J van der Watt; Christopher P Maske; Denver T Hendricks; M Iqbal Parker; Lynette Denny; Dhirendra Govender; Michael J Birrer; Virna D Leaner Journal: Int J Cancer Date: 2009-04-15 Impact factor: 7.396
Authors: Christiane Klec; Erik Knutsen; Daniela Schwarzenbacher; Katharina Jonas; Barbara Pasculli; Ellen Heitzer; Beate Rinner; Katarina Krajina; Felix Prinz; Benjamin Gottschalk; Peter Ulz; Alexander Deutsch; Andreas Prokesch; Stephan W Jahn; S Mohammad Lellahi; Maria Perander; Raffaela Barbano; Wolfgang F Graier; Paola Parrella; George Adrian Calin; Martin Pichler Journal: Cell Mol Life Sci Date: 2022-07-01 Impact factor: 9.207